Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 2,309,850 |
|
|||||
| News | - | ||||||
| Day High | 111.29 | Low High |
|||||
| Day Low | 106.64 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moderna Inc | MRNA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.38 | 0.35% | 108.27 | 13:46:21 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 111.05 | 106.64 | 111.29 | 107.89 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 35,816 | 2,309,850 | $ 108.23 | $ 249,984,971 | - | 62.55 - 142.79 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:46:24 | average | 100 | $ 108.2265 | USD |
Moderna (MRNA) Options Flow Summary
Moderna Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 41.3B | 382.07M | - | 6.85B | -4.71B | -12.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Moderna News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRNA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 104.51 | 111.29 | 99.30 | 103.94 | 2,415,112 | 3.76 | 3.60% |
| 1 Month | 109.60 | 115.89 | 97.00 | 105.87 | 3,216,111 | -1.33 | -1.21% |
| 3 Months | 102.47 | 115.89 | 84.06 | 100.44 | 3,839,820 | 5.80 | 5.66% |
| 6 Months | 78.81 | 115.97 | 62.55 | 93.38 | 4,440,731 | 29.46 | 37.38% |
| 1 Year | 140.79 | 142.79 | 62.55 | 102.84 | 4,039,024 | -32.52 | -23.10% |
| 3 Years | 171.79 | 497.17 | 62.55 | 219.70 | 6,993,383 | -63.52 | -36.98% |
| 5 Years | 24.80 | 497.17 | 11.54 | 147.55 | 8,791,595 | 83.47 | 336.57% |
Moderna Description
| Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |
